Lv51
1440 积分 2023-09-06 加入
Single-cell profiling of immune reset in patients with refractory generalized myasthenia gravis receiving autologous CD19/BCMA CAR-T cell therapy
3个月前
已完结
Global epidemiology and burden of interstitial lung disease
3个月前
已完结
Teclistamab in Relapsed or Refractory Multiple Myeloma
3个月前
已完结
Standardization of Myasthenia Gravis Outcome Measures in Clinical Practice. A Report of the MGFA Task Force
3个月前
已完结
Non-ICANS neurological complications after CAR T-cell therapies: recommendations from the EBMT Practice Harmonisation and Guidelines Committee
3个月前
已完结
Bispecific T cell engager therapy for refractory rheumatoid arthritis
4个月前
已完结
Interstitial lung diseases
4个月前
已完结
Interstitial lung disease in connective tissue disease—mechanisms and management
4个月前
已完结
BCMA-Targeted T-Cell–Engager Therapy for Autoimmune Disease
4个月前
已完结
Bispecific T cell engager therapy for refractory rheumatoid arthritis
4个月前
已完结
皖公网安备34019202002308
